Gladstone Commercial Preferred GOODN Rises 098 Approaches Key Resistance Level Biotech and Pharma Stocks Slide as Sector Rotation Favors Energy Barrons ACAD Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain Nearly Half of US Households Struggled to Cover Necessities in 2024 Report Finds